OKYO Pharma Limited
OKYO
$2.42
$0.052.11%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 0.00% | 230.62% | |||
| Gross Profit | 0.00% | -230.62% | |||
| SG&A Expenses | -- | -- | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.00% | 12.38% | |||
| Operating Income | 0.00% | -12.38% | |||
| Income Before Tax | 0.00% | 5.50% | |||
| Income Tax Expenses | 0.00% | -30.20% | |||
| Earnings from Continuing Operations | 0.00% | 24.38% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.00% | 24.38% | |||
| EBIT | 0.00% | -12.38% | |||
| EBITDA | 0.00% | -12.38% | |||
| EPS Basic | 0.00% | 44.11% | |||
| Normalized Basic EPS | 0.00% | 29.92% | |||
| EPS Diluted | 0.00% | 44.11% | |||
| Normalized Diluted EPS | 0.00% | 29.92% | |||
| Average Basic Shares Outstanding | 0.00% | 35.24% | |||
| Average Diluted Shares Outstanding | 0.00% | 35.24% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||